The FDA recently approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.
with 83% of them classified as severe1. Bipolar disorder is a group of disorders that are characterized by periods of elevated mood alternating with periods of depressed mood. For the diagnosis of bipolar I disorder, people must have experienced...
Pfizer's drug product is the first FDA-approved intravenous immunoglobulin with 2 maintenance dosing options for CIDP. Officials with the FDA have approved the supplemental Biologics License Application for Pfizer’s immune globulin intravenous [human] — ifas (Panzyga) 10% liquid preparat...
aripiprazole, and olanzapine had a higher incidence of stroke and transient ischemic attack, including fatal stroke. REXULTI is not approved for the treatment of patients with dementia-related psychosis.
The FDA previously granted Priority Review for the sNDA, a designation for a drug application that, if approved, would represent a significant improvement in the safety and/or effectiveness of the treatment, diagnosis, or prevention of a serious medical condition. REXULTI was approved in the...
Results The majority of antipsychotic prescribing is for "off label" conditions. Of the elderly 65+ treated with antipsychotics in 2010, 32.8% had a diagnosis of dementia, 24.3% anxiety disorder, and 20.9% depression; 11.3% and 10.8% were for approved conditions bipolar disorder and schizophrenia...
Inspired by our finding, National Institute on Addiction (NIDA) is planning a prospective clinical trial of olanzapine in treating OUD. The strong positive association between OUD and type 2 diabetes suggests that controlling type 2 diabetes may prevent or mitigate OUD. Due to limited usage of ...